WO2025088589 - TOPICAL FOAM COMPOSITION OF ROFLUMILAST
National phase entry:
Publication Number
WO/2025/088589
Publication Date
01.05.2025
International Application No.
PCT/IB2024/060558
International Filing Date
26.10.2024
Title **
[English]
TOPICAL FOAM COMPOSITION OF ROFLUMILAST
[French]
COMPOSITION DE MOUSSE TOPIQUE DE ROFLUMILAST
Applicants **
GLENMARK PHARMACEUTICALS LIMITED
Inventors
DHUPPAD, Ulhas
OTAVKAR, Roopali
CHOPADE, Atul
ABRAHAM, Jaya
MASHERE, Kiran
Priority Data
202321073408
27.10.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2294 | |
| EPO | Filing, Examination, Granting | 14040 | |
| Japan | Filing, Examination, Granting | 2340 | |
| South Korea | Filing, Examination, Granting | 2444 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
25,858
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a topical composition comprising roflumilast or a pharmaceutically acceptable salts thereof. Further the invention relates to a process of preparing the composition and its method of use for treating skin disorder. The present invention particularly relates to a topical foam composition comprising roflumilast or a pharmaceutically acceptable salts thereof.[French]
La présente invention concerne une composition topique comprenant du roflumilast ou un sel pharmaceutiquement acceptable de celui-ci. En outre, l'invention concerne un procédé de préparation de la composition et son procédé d'utilisation pour traiter un trouble cutané. La présente invention concerne en particulier une composition de mousse topique comprenant du roflumilast ou un sel pharmaceutiquement acceptable de celui-ci.